Natarajan Sethuraman
Chief Tech/Sci/R&D Officer at ENTRADA THERAPEUTICS, INC.
Net worth: 3 M $ as of 30/04/2024
Profile
Natarajan Sethuraman is currently the Chief Scientific Officer at Entrada Therapeutics, Inc. Previously, he worked at Merck & Co., Inc. as the Executive Director & Head-GlycoFi Site from 2012 to 2016.
He also worked as a Senior Scientist at Medical Enzymes AG.
Dr. Sethuraman received his graduate and doctorate degrees from the Indian Agricultural Research Institute and his undergraduate degree from Tamilnadu Agricultural University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ENTRADA THERAPEUTICS INC
0.62% | 05/03/2024 | 209,032 ( 0.62% ) | 3 M $ | 30/04/2024 |
Natarajan Sethuraman active positions
| Companies | Position | Start |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2017 |
Former positions of Natarajan Sethuraman
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Director/Board Member | 01/07/2016 |
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - |
Training of Natarajan Sethuraman
| Indian Agricultural Research Institute | Doctorate Degree |
| Tamilnadu Agricultural University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
- Stock Market
- Insiders
- Natarajan Sethuraman